ORAL VERSUS VAGINAL MISOPROSTOL FOR INDUCTION OF LABOUR IN UNIVERSITY OF MAIDUGURI TEACHING HOSPITAL. A RANDOMISED CONTROLLED TRIAL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202401578504771

Enrollment

100

Registered

2024-01-23

Start date

2022-04-27

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Oral misoprostol for induction of labour

vaginal misoprostol

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The following inclusion criteria will be applied: 1) All booked pregnant women who are planned for induction of labour at term with singleton pregnancy presenting cephalic and with favourable cervix (Bishop score of =6). 2) Patients that are informed, counseled, and consented to participate in the study. 3) Patients that is para 0 to 4. 4) No known contraindications to misoprostol

Exclusion criteria

Exclusion criteria: The following criterial will be excluded 1) Previous uterine scar and/or malpresentation 2) Antepartum heamorrhage. 3) Patients with intrauterine fetal death, HIV, active hepatitis B infection 4) Patients refusal to consent

Design outcomes

Primary

Measure	Time frame
The primary outcome will be incidence of vaginal delivery in both arms	—

Secondary

Measure	Time frame
secondary outcomes will be induction-delivery interval, fetal heart abnormalities (tachycardia, bradycardia), maternal satisfaction, adverse effects of misoprostol fever, shivering, nausea, vomiting, and diarrhoea, Apgar score at fifth minute, and number of caesarean sections in both arms.	—

Countries

Nigeria

Contacts

Public ContactIhefobi Angela Chikaodili

Nurse

akinjoe83@gmail.com08104351088

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026